Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Published 09/04/2024, 11:05
Updated 09/04/2024, 12:10
© Reuters.  Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

Biophytis posted a FY23 loss of €0.03 per share, versus a year-ago loss of €0.14 per share, according to data from Benzinga Pro.

Biophytis shares jumped 55.2% to $0.4920 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) shares rose 40% to $3.64 in pre-market trading after jumping 22% on Monday.
  • MediaCo Holding Inc. (NASDAQ: MDIA) shares rose 20.2% to $3.63 in pre-market trading after falling 22% on Monday. On April 4, an SEC filing showed Standard General L.P. reported a 95.2% stake in the company, as of April 1.
  • Destiny Tech100 Inc. (NASDAQ: DXYZ) gained 18.5% to $118.33 in pre-market trading after jumping over 68% on Monday.
  • Addex Therapeutics Ltd (NASDAQ: ADXN) shares gained 17.2% to $25.60 in pre-market trading after jumping around 21% on Monday. Addex Therapeutics and funds affiliated with Perceptive Advisors, last week, announced the launch of Neurosterix.
  • Anghami Inc. (NASDAQ: ANGH) gained 16.1% to $1.30 in pre-market trading after dipping over 3% on Monday.
  • Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) climbed 15% to $0.8395 in pre-market trading after jumping around 12% on Monday. The company, last week, reported FY23 financial results.
  • Soligenix, Inc. (NASDAQ: SNGX) shares gained 12.5% to $0.54 in pre-market trading after adding around 3% on Monday.
  • TuanChe Limited (NASDAQ: TC) rose 10.8% to $2.16 in pre-market trading.
  • Halozyme Therapeutics, Inc. (NASDAQ: HALO) gained 10.7% to $2.16 in pre-market trading after declining around 3% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Vincerx Pharma, Inc. (NASDAQ: VINC) declined 52.1% to $2.29 in pre-market trading after the company presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the AACR Annual Meeting 2024.
  • Focus Universal Inc. (NASDAQ: FCUV) fell 30.8% to $0.2424 in pre-market trading. Focus Universal, on Monday, announced Warren Wang as Chief Strategy Officer.
  • UTime Limited (NASDAQ: WTO) fell 26.1% to $0.2216 in pre-market trading. UTime shares jumped 62% on Monday after the company completed a private placement.
  • BioSig Technologies, Inc. (NASDAQ: BSGM) fell 22.8% to $0.9570 in pre-market trading after jumping over 96% on Monday.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares declined 20.8% to $7.05 in pre-market trading.
  • Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) fell 16.8% to $2.27 pre-market trading. Maxeon Solar said it sees preliminary fourth-quarter revenue of $229 million versus market estimates of $235.959 million.
  • Hanryu Holdings, Inc. (NASDAQ: HRYU) shares fell 15.8% to $0.24 in pre-market trading after jumping over 31% on Monday.
  • VBI Vaccines Inc. (NASDAQ: VBIV) fell 12.4% to $0.8037 in pre-market trading after jumping around 30% on Monday.
  • Eco Wave Power Global AB (NASDAQ: WAVE) shares fell 11.2% to $3.73 in pre-market trading. Eco Wave. Power global shares jumped 219% on Monday after the company announced that it was selected by an international energy company to conduct wave energy feasibility studies for the U.S. coastline.
  • DigiAsia Corp. (NASDAQ: FAAS) fell 9.9% to $7.00 pre-market trading after surging over 20% on Monday.

Now Read This: Neogen, Maxeon Solar Technologies And 3 Stocks To Watch Heading Into Tuesday

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.